CVE-2019-10964
Medtronic MiniMed 508 and Paradigm Series Insulin Pumps Improper Access Control
- Published
- Updated
- Reserved
- Assigned by
- icscert
Description
Medtronic MiniMed Insulin Pumps are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| icscertCNA (assigner) | 3.1 | High7.1 | CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:H |
| NVDNVD · Modified | 3.1 | High7.1 | CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:H |
- EPSS (exploitation in 30 days)
- 1.2% · top 31% of all CVEs (6 Nov 2026)
The list uses the assigner's score when there is one, then CISA's, then NVD's: High 7.1.
Weakness
Affected products
- affected All versions
Medtronic · MiniMed Paradigm 511 pump
- affected All versions
Medtronic · MiniMed Paradigm 512/712 pumps
- affected All versions
Medtronic · MiniMed Paradigm 712E pump
- affected All versions
Medtronic · MiniMed Paradigm 515/715 pumps
- affected All versions
Medtronic · MiniMed Paradigm 522/722 pumps
- affected All versions
Medtronic · MiniMed Paradigm 522K/722K pumps
- affected All versions
Medtronic · MiniMed Paradigm 523/723 pumps
- affected ≤ Software Versions 2.4A
Medtronic · MiniMed Paradigm 523K/723K pumps
- affected ≤ Software Versions 2.4A
Medtronic · MiniMed Paradigm Veo 554/754 pumps
- affected ≤ Software Versions 2.6A
Medtronic · MiniMed Paradigm Veo 554CM/754CM pumps
- affected ≤ Software Versions 2.7A
What to do
Workaround: Medtronic recommends U.S. patients who are currently using the affected products talk to their healthcare provider about changing to a newer model insulin pump with increased cybersecurity protection. Patients outside the U.S. will receive a notification letter with instructions based on the country where they live. Medtronic recommends all patients take the cybersecurity precautions indicated below. CYBERSECURITY PRECAUTIONS RECOMMENDED FOR ALL PATIENTS: * Maintain tight physical control of the pump and devices connected to the pump * Do not share pump serial number * Be attentive to pump notifications, alarms, and alerts * Immediately cancel any unintended boluses (a single dose of insulin administered all at once) * Do not connect to any third-party devices or use any software not authorized by Medtronic * Disconnect CareLink USB devices from computers when not being used to download data from the pump * Monitor blood glucose levels closely and act as appropriate * Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis, or suspect an insulin pump settings, or insulin delivery have changed unexpectedly Medtronic has released additional patient-focused information, at the following location: https://www.medtronic.com/security
References (4)
- https://global.medtronic.com/xg-en/product-security/security-bulletins/minimed-508-paradigm.html (opens in a new tab)
- 108926 (opens in a new tab)
- http://www.securityfocus.com/bid/108926 (opens in a new tab)vdb-entryx_refsource_BIDx_transferred
- https://www.us-cert.gov/ics/advisories/icsma-19-178-01 (opens in a new tab)x_refsource_MISCx_transferred
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Badge for a README or a ticket
[](https://trackcve.app/cve/CVE-2019-10964)Record last updated .